Prolisa™ Quantitative Anti-SARS-CoV-2 IgG EIA
Prolisa™ Quantitative Anti-SARS-CoV-2 IgG EIA is intended for the quantitative detection of human immunoglobulins G (IgG) against SARS-CoV-2 in human serum and K2-EDTA, lithium heparin and citrate plasma. It works as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating antibody titers of infection and/or vaccination.








